CEACAM5 and cancer: CRP, LDH, CA15‐3 and CEA have been widely investigated in veterinary medicine, and numerous novel biomarkers, such as cancer CSCs, CTCs, miRNAs and cfDNA, have been explored for diagnosing CMTs.